查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420114

头孢菌素药物的全球市场：按世代、给药途径、应用、地区和国家分類的分析、市场考虑因素和预测

Global Cephalosporin Drug Market : Analysis by Generation, Route of Administration, Application, By Region, By Country: Market Insights and Forecast
出版日期: | 出版商: Azoth Analytics | 英文 260 Pages | 订单完成后即时交付

价格

全球头孢菌素类药物市场规模预计将从2022年的132.7亿美元增加到2029年终的219亿美元。全球头孢菌素药物市场的有利成长要素是细菌感染疾病的流行、抗生素抗药性模式、监管核准和新製剂的推出。预计2024-2029年期间，全球头孢菌素药品市场将以7.5%的复合年增长率扩张。製药公司致力于开发新一代头孢菌素製剂来对抗抗药性细菌。新一代药物的开发、联合治疗、缓释性和扩大适应症都促进了头孢菌素药物的发展。

全球细菌感染疾病（包括呼吸道感染疾病、尿道感染、皮肤软组织感染疾病和腹腔内感染疾病）的高盛行率和不断增加的盛行率是一个重要的驱动因素。头孢菌素是治疗这些感染疾病的常用抗生素，从而推动了对头孢菌素药物的需求。

疫情期间，由于封锁、运输限制和工厂关闭，全球药品供应链面临中断。这些中断影响了药物（包括头孢菌素药物）的生产、分销和供应。然而，已采取行动减轻影响并确保基本药物的持续供应。这场大流行也扰乱了正在进行的临床试验，并推迟了新临床试验的开始，包括与头孢菌素药物开发相关的临床试验。这种中断可能影响了新头孢菌素的引入和扩大其使用的时间表。

正在进行的研究和开发正在开发先进的药物输送系统，包括吸入製剂和新型呼吸装置。这些技术旨在增强头孢菌素药物向呼吸道的靶向输送，提高疗效并最大限度地减少副作用。

缓释性旨在较长时间内逐渐释放头孢菌素製剂，从而减少给药频率。这提高了病人用药医嘱遵从性和便利性。药物控制释放技术的进步，例如控释机制，可以确保治疗效果的持久性，并降低与药物快速释放相关的副作用的风险。

药品製造中的连续製造流程在效率、成本效益和品管方面具有优势。将这些製程应用于头孢菌素生产将导致生产流程更加精简和可扩展。智慧包装还结合了无线射频识别 (RFID) 和 QR 码等技术来监控药品储存、追踪有效期并提高整体产品完整性。这确保了头孢菌素类药物在整个生命週期中的品质和稳定性。

该报告研究了全球头孢菌素药品市场，并提供包括市场规模和预测、区域和细分市场分析以及主要趋势和机会在内的资讯。

目录

第一章 市集背景

  • 产品范围和产品前景
  • 执行摘要
  • 调查方法

第二章 战略建议

第三章全球头孢菌素药物市场：表现与预测（2019-2029）

  • 宏观经济因素对全球头孢菌素类药品市场的影响分析
  • 管道场景
  • 全球与抗菌素抗药性相关的死亡
  • 流行病学：全球感染疾病流行情况
  • 流行病学：全球感染疾病率
  • 全球头孢菌素药物市场：市场规模与复合年增长率（2019-2029）
  • COVID-19对头孢菌素药品市场的影响
  • 全球头孢菌素药物市场区隔：按世代
    • 全球头孢菌素药物市场：世代、概述
    • 全球头孢类药物市场规模：第一代（金额）（2019-2029）
    • 全球头孢类药物市场规模：第二代（金额）（2019-2029）
    • 全球头孢菌素药物市场规模：第三代（金额）（2019-2029）
    • 全球头孢类药物市场规模：第四代（金额）（2019-2029）
    • 全球头孢菌素药物市场规模：第五代（金额）（2019-2029）
  • 全球头孢菌素药物市场区隔：依给药途径
    • 全球头孢菌素药物市场：依给药途径概述
    • 全球头孢菌素类药物市场规模：口服（金额）（2019-2029）
    • 全球头孢菌素类药物市场规模：注射用（金额）（2019-2029）
  • 全球头孢菌素药物市场区隔：按应用
    • 全球头孢菌素药品市场：按应用、概述
    • 全球头孢类药物市场规模：呼吸道感染疾病（金额）（2019-2029）
    • 全球头孢菌素类药物市场规模：皮肤感染疾病（金额）（2019-2029）
    • 全球头孢菌素类药物市场规模：尿道感染（金额）（2019-2029）
    • 全球头孢菌素类药物市场规模：其他（金额）（2019-2029）

第四章全球头孢菌素药物市场、区域分析

  • 研究区域范围
  • 区域简介

第五章美洲头孢菌素药品市场：表现与预测（2019-2029）

  • 美洲头孢菌素药品市场：概况
  • 美洲头孢菌素药品市场：市场规模与复合年增长率（2019-2029）
  • 美洲头孢菌素药品市场：主要驱动因素
  • 美洲头孢菌素药品市场：細項分析
  • 美洲头孢菌素药物市场区隔：按世代
  • 美洲头孢菌素药物市场区隔依给药途径细分
  • 美洲头孢菌素药品市场区隔：依应用
  • 美洲头孢菌素药品市场区隔：按国家/地区划分
    • 美洲头孢菌素药品市场：依国家/地区、概述
    • 美国头孢菌素药物市场：市场规模与复合年增长率（2019-2029）
    • 加拿大头孢菌素药物市场：市场规模与复合年增长率（2019-2029）
    • 其他美洲头孢菌素药物市场：市场规模和复合年增长率（2019-2029）

第六章欧洲头孢菌素药物市场：表现与预测（2019-2029）

  • 欧洲头孢菌素药品市场：概况
  • 欧洲头孢菌素药物市场：市场规模与复合年增长率（2019-2029）
  • 欧洲头孢菌素药品市场：主要驱动因素
  • 欧洲头孢菌素药品市场：細項分析
  • 欧洲头孢菌素药物市场区隔：按世代
  • 欧洲头孢菌素药物市场区隔：依给药途径
  • 欧洲头孢菌素药物市场区隔：按应用
  • 欧洲头孢菌素药物市场区隔：按国家/地区
    • 欧洲头孢菌素药物市场：按国家划分，概述
    • 英国头孢菌素药物市场：市场规模与复合年增长率（2019-2029）
    • 德国头孢菌素药品市场：市场规模与复合年增长率（2019-2029）
    • 法国头孢菌素药物市场：市场规模与复合年增长率（2019-2029）
    • 义大利头孢菌素药物市场：市场规模与复合年增长率（2019-2029）
    • 其他欧洲头孢菌素药物市场：市场规模和复合年增长率（2019-2029）

第七章亚太地区头孢菌素药物市场：表现与预测（2019-2029）

  • 亚太地区头孢菌素药物市场：概况
  • 亚太地区头孢菌素药物市场：市场规模与复合年增长率（2019-2029）
  • 亚太地区头孢菌素药物市场：主要驱动因素
  • 亚太地区头孢菌素药品市场：細項分析
  • 亚太地区头孢菌素药物市场区隔：按世代
  • 亚太地区头孢菌素药物市场区隔：依给药途径
  • 亚太地区头孢菌素药品市场区隔：依应用
  • 亚太地区头孢菌素药物市场区隔：按国家/地区
    • 亚太地区头孢菌素药物市场：按国家/地区划分，概述
    • 中国头孢类药物市场：市场规模及复合年增长率（2019-2029）
    • 日本头孢菌素药品市场：市场规模与复合年增长率（2019-2029）
    • 韩国头孢菌素药品市场：市场规模与复合年增长率（2019-2029）
    • 印度头孢菌素药物市场：市场规模与复合年增长率（2019-2029）
    • 其他亚太地区头孢菌素药物市场：市场规模和复合年增长率（2019-2029）

第8章中东与非洲头孢菌素药品市场：表现与预测（2019-2029）

  • 中东和非洲头孢菌素药品市场：概况
  • 中东和非洲头孢菌素药品市场：市场规模和复合年增长率（2019-2029）
  • 中东和非洲头孢菌素药品市场：主要驱动因素
  • 中东和非洲头孢菌素药品市场：細項分析
  • 中东和非洲头孢菌素药品市场区隔：按世代
  • 中东和非洲头孢菌素药物市场区隔：按给药途径
  • 中东和非洲头孢菌素药品市场区隔：按应用

第九章市场动态

  • 评估市场动态对全球头孢菌素药品市场的影响
  • 促进因素
  • 抑制因素
  • 趋势

第10章产业生态系分析

  • 波特五力分析

第十一章竞争定位

  • 企业产品定位
  • 主要企业市场占有率
  • 公司简介
    • Lupin Limited
    • Baxter International
    • F. Hoffmann-La Roche AG
    • Eli Lilly and Company
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Novartis
    • Sanofi
    • Pfizer
    • Teva Pharmaceutical

Executive Summary

Azoth Analytics has released a research report titled "Global Cephalosporin Drug Market (2024 Edition)" which provides a complete analysis of the Global Cephalosporin Drug industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), By Route of Administration (Oral, Parenteral), By Application (Respiratory Tract Infection, Skin Infection, Urinary Tract Infection, Others), By Region (Americas , Europe, Asia-pacific, Middle-East & Africa), for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Italy, China, Japan, South Korea, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Cephalosporin Drug Market is expected to generate USD 21.9 Billion by the end of 2029, up from USD 13.27 Billion in 2022. A favourable growth element for the global Cephalosporin Drug market is propelled by the prevalence of bacterial infections, antibiotic resistance patterns, regulatory approvals, and the introduction of new formulations. During the forecast period, 2024-2029, Global Cephalosporin Drug is expected to expand at a CAGR of 7.5%. Pharmaceutical companies have focused on developing advanced generations of Cephalosporin drugs to combat bacterial resistance. The development of new generations, combination therapies, extended-release formulations, and expanded indications all contribute to the evolving landscape of Cephalosporin drugs.

The high and growing incidence of bacterial infections worldwide, such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections, is a significant driving factor. Cephalosporins are commonly prescribed antibiotics for treating these infections, which fuels the demand for Cephalosporin drugs.

The global pharmaceutical supply chains faced disruptions due to lockdowns, transportation restrictions, and factory closures during the pandemic. These disruptions affected the production, distribution, and availability of pharmaceutical products, including Cephalosporin drugs. However, efforts were made to mitigate the impact and ensure a continued supply of essential medications. Also, the pandemic disrupted ongoing clinical trials and delayed the initiation of new trials, including those related to the development of Cephalosporin drugs. This interruption may have impacted the timeline for introducing new Cephalosporins or exploring their expanded uses.

According to the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), Globally, the incidence of Upper Respiratory Infection reached 17*2 billion. Ongoing research involves the development of advanced drug delivery systems, such as inhalable formulations or novel respiratory devices. These technologies aim to enhance the targeted delivery of cephalosporin drugs to the respiratory tract, improving efficacy and minimizing side effects.

Extended-release formulations are designed to release the cephalosporin drug gradually over an extended period, allowing for less frequent dosing. This can lead to improved patient adherence and convenience. Advances in drug delivery technologies, such as controlled-release mechanisms, ensure a sustained therapeutic effect and potentially reduce the risk of side effects associated with rapid drug release.

Continuous manufacturing processes in pharmaceutical production offer advantages in terms of efficiency, cost-effectiveness, and quality control. Applying these processes to cephalosporin production contribute to a more streamlined and scalable manufacturing pipeline. Also, Smart packaging involves incorporating technologies like RFID (Radio-Frequency Identification) or QR codes to monitor drug storage conditions, track expiration dates, and enhance overall product integrity. This ensures the quality and stability of cephalosporin drugs throughout their lifecycle.

Scope of the Report

  • The report analyses the Cephalosporin Drug Market by Value (USD Million).
  • The report presents the analysis of the Cephalosporin Drug Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
  • The report analyses the Cephalosporin Drug Market by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation).
  • The report analyses the Cephalosporin Drug Market by Route of Administration (Oral, Parenteral).
  • The report analyses the Cephalosporin Drug Market by Application (Respiratory Tract Infection, Skin Infection, Urinary Tract Infection, Others).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Lupin Limited, Baxter International, F. Hoffmann-La Roche AG, Eli Lilly and Company, Abbott Laboratories, Merck & Co., Inc., Novartis, Sanofi, Pfizer, Teva Pharmaceutical.

Table of Contents

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Strategic Recommendations

3. Global Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 3.1 Impact Analysis of Macro Economic Factors on Global Cephalosporin Drug Market
  • 3.2 Pipeline Scenario
  • 3.3 Global deaths associated with bacterial antimicrobial resistance
  • 3.4 Epidemiology: Global Infectious Disease Prevalence
  • 3.5 Epidemiology: Global Infectious Disease Incidence
  • 3.6 Global Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 3.7 Degree of Impact of Covid-19 on Cephalosporin Drug Market
  • 3.8 Global Cephalosporin Drug Market Segmentation : By Generation
    • 3.8.1 Global Cephalosporin Drug Market, By Generation Overview
    • 3.8.2 Global Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.3 Global Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.4 Global Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.5 Global Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.6 Global Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 3.9 Global Cephalosporin Drug Market Segmentation : By Route of Administration
    • 3.9.1 Global Cephalosporin Drug Market, By Route of Administration Overview
    • 3.9.2 Global Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.9.3 Global Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 3.10 Global Cephalosporin Drug Market Segmentation : By Application
    • 3.10.1 Global Cephalosporin Drug Market, By Application Overview
    • 3.10.2 Global Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.10.3 Global Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.10.4 Global Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.10.5 Global Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)

4. Global Cephalosporin Drug Market, Regional Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 5.1 Americas Cephalosporin Drug Market: Snapshot
  • 5.2 Americas Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 5.3 Americas Cephalosporin Drug Market: Key Factors
  • 5.4 Americas Cephalosporin Drug Market: Segment Analysis
  • 5.5 Americas Cephalosporin Drug Market Segmentation : By Generation
    • 5.5.1 Americas Cephalosporin Drug Market, By Generation Overview
    • 5.5.2 Americas Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.3 Americas Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.4 Americas Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.5 Americas Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.6 Americas Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.6 Americas Cephalosporin Drug Market Segmentation : By Route of Administration
    • 5.6.1 Americas Cephalosporin Drug Market, By Route of Administration Overview
    • 5.6.2 Americas Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.6.3 Americas Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.7 Americas Cephalosporin Drug Market Segmentation : By Application
    • 5.7.1 Americas Cephalosporin Drug Market, By Application Overview
    • 5.7.2 Americas Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.3 Americas Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.4 Americas Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.5 Americas Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.8 Americas Cephalosporin Drug Market Segmentation : By Country
    • 5.8.1 Americas Cephalosporin Drug Market, By Country Overview
    • 5.8.2 United States Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.8.2.1 United States Cephalosporin Drug Market, By Generation
      • 5.8.2.2 United States Cephalosporin Drug Market, By Route of Administration
      • 5.8.2.3 United States Cephalosporin Drug Market, By Application
    • 5.8.3 Canada Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.8.3.1 Canada Cephalosporin Drug Market, By Generation
      • 5.8.3.2 Canada Cephalosporin Drug Market, By Route of Administration
      • 5.8.3.3 Canada Cephalosporin Drug Market, By Application
    • 5.10.4 Rest of Americas Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.10.4.1 Rest of Americas Cephalosporin Drug Market, By Generation
      • 5.10.4.2 Rest of Americas Cephalosporin Drug Market, By Route of Administration
      • 5.10.4.3 Rest of Americas Cephalosporin Drug Market, By Application

6. Europe Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 6.1 Europe Cephalosporin Drug Market: Snapshot
  • 6.2 Europe Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 6.3 Europe Cephalosporin Drug Market: Key Factors
  • 6.4 Europe Cephalosporin Drug Market: Segment Analysis
  • 6.5 Europe Cephalosporin Drug Market Segmentation : By Generation
    • 6.5.1 Europe Cephalosporin Drug Market, By Generation Overview
    • 6.5.2 Europe Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.3 Europe Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.4 Europe Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.5 Europe Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.6 Europe Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.6 Europe Cephalosporin Drug Market Segmentation : By Route of Administration
    • 6.6.1 Europe Cephalosporin Drug Market, By Route of Administration Overview
    • 6.6.2 Europe Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.6.3 Europe Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.7 Europe Cephalosporin Drug Market Segmentation : By Application
    • 6.7.1 Europe Cephalosporin Drug Market, By Application Overview
    • 6.5.2 Europe Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.3 Europe Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.4 Europe Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.7.5 Europe Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.8 Europe Cephalosporin Drug Market Segmentation : By Country
    • 6.8.1 Europe Cephalosporin Drug Market, By Country Overview
    • 6.8.2 United Kingdom Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.2.1 United Kingdom Cephalosporin Drug Market, By Generation
      • 6.8.2.2 United Kingdom Cephalosporin Drug Market, By Route of Administration
      • 6.8.2.3 United Kingdom Cephalosporin Drug Market, By Application
    • 6.8.3 Germany Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.3.1 Germany Cephalosporin Drug Market, By Generation
      • 6.8.3.2 Germany Cephalosporin Drug Market, By Route of Administration
      • 6.8.3.3 Germany Cephalosporin Drug Market, By Application
    • 6.8.4 France Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.4.1 France Cephalosporin Drug Market, By Generation
      • 6.8.4.2 France Cephalosporin Drug Market, By Route of Administration
      • 6.8.4.3 France Cephalosporin Drug Market, By Application
    • 6.8.5 Italy Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.5.1 Italy Cephalosporin Drug Market, By Generation
      • 6.8.5.2 Italy Cephalosporin Drug Market, By Route of Administration
      • 6.8.5.3 Italy Cephalosporin Drug Market, By Application
    • 6.8.6 Rest of Europe Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.6.1 Rest of Europe Cephalosporin Drug Market, By Generation
      • 6.8.6.2 Rest of Europe Cephalosporin Drug Market, By Route of Administration
      • 6.8.6.3 Rest of Europe Cephalosporin Drug Market, By Application

7. Asia Pacific Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 7.1 Asia Pacific Cephalosporin Drug Market: Snapshot
  • 7.2 Asia Pacific Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 7.3 Asia Pacific Cephalosporin Drug Market: Key Factors
  • 7.4 Asia Pacific Cephalosporin Drug Market: Segment Analysis
  • 7.5 Asia Pacific Cephalosporin Drug Market Segmentation : By Generation
    • 7.5.1 Asia Pacific Cephalosporin Drug Market, By Generation Overview
    • 7.5.2 Asia Pacific Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.3 Asia Pacific Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.4 Asia Pacific Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.5 Asia Pacific Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.6 Asia Pacific Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.6 Asia Pacific Cephalosporin Drug Market Segmentation : By Route of Administration
    • 7.6.1 Asia Pacific Cephalosporin Drug Market, By Route of Administration Overview
    • 7.6.2 Asia Pacific Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.6.3 Asia Pacific Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.7 Asia Pacific Cephalosporin Drug Market Segmentation : By Application
    • 7.7.1 Asia Pacific Cephalosporin Drug Market, By ApplicationOverview
    • 7.7.2 Asia Pacific Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.3 Asia Pacific Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.4 Asia Pacific Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.5 Asia Pacific Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.8 Asia Pacific Cephalosporin Drug Market Segmentation : By Country
    • 7.8.1 Asia Pacific Cephalosporin Drug Market, By Country Overview
    • 7.8.2 China Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.2.1 China Cephalosporin Drug Market, By Generation
      • 7.8.2.2 China Cephalosporin Drug Market, By Route of Administration
      • 7.8.2.3 China Cephalosporin Drug Market, By Application
    • 7.8.3 Japan Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.3.1 Japan Cephalosporin Drug Market, By Generation
      • 7.8.3.2 Japan Cephalosporin Drug Market, By Route of Administration
      • 7.8.3.3 Japan Cephalosporin Drug Market, By Application
    • 7.8.4 South Korea Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.4.1 South Korea Cephalosporin Drug Market, By Generation
      • 7.8.4.2 South Korea Cephalosporin Drug Market, By Route of Administration
      • 7.8.4.3 South Korea Cephalosporin Drug Market, By Application
    • 7.8.5 India Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.5.1 India Cephalosporin Drug Market, By Generation
      • 7.8.5.2 India Cephalosporin Drug Market, By Route of Administration
      • 7.8.5.3 India Cephalosporin Drug Market, By Application
    • 7.8.6 Rest of Asia Pacific Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.6.1 Rest of Asia Pacific Cephalosporin Drug Market, By Generation
      • 7.8.6.2 Rest of Asia Pacific Cephalosporin Drug Market, By Route of Administration
      • 7.8.6.3 Rest of Asia Pacific Cephalosporin Drug Market, By Application

8. Middle East and Africa Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 8.1 Middle East and Africa Cephalosporin Drug Market: Snapshot
  • 8.2 Middle East and Africa Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 8.3 Middle East and Africa Cephalosporin Drug Market: Key Factors
  • 8.4 Middle East and Africa Cephalosporin Drug Market: Segment Analysis
  • 8.5 Middle East and Africa Cephalosporin Drug Market Segmentation : By Generation
    • 8.5.1 Middle East and Africa Cephalosporin Drug Market, By Generation Overview
    • 8.5.2 Middle East and Africa Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.3 Middle East and Africa Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.4 Middle East and Africa Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.5 Middle East and Africa Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.6 Middle East and Africa Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 8.6 Middle East and Africa Cephalosporin Drug Market Segmentation : By Route of Administration
    • 8.6.1 Middle East and Africa Cephalosporin Drug Market, By Route of Administration Overview
    • 8.6.2 Middle East and Africa Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.6.3 Middle East and Africa Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 8.7 Middle East and Africa Cephalosporin Drug Market Segmentation : By Application
    • 8.7.1 Middle East and Africa Cephalosporin Drug Market, By Application Overview
    • 8.7.2 Middle East and Africa Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.3 Middle East and Africa Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.4 Middle East and Africa Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.5 Middle East and Africa Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)

9. Market Dynamics

  • 9.1 Impact Assessment of Market Dynamics on the Global Cephalosporin Drug Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Industry Ecosystem Analysis

  • 10.1 Porter's Five Forces Analysis

11. Competitive Positioning

  • 11.1 Companies' Product Positioning
  • 11.2 Market Share of Leading Companies
  • 11.3 Company Profiling
    • 11.3.1 Lupin Limited
    • 11.3.2 Baxter International
    • 11.4.3 F. Hoffmann-La Roche AG
    • 11.3.4 Eli Lilly and Company
    • 11.3.5 Abbott Laboratories
    • 11.3.6 Merck & Co., Inc.
    • 11.3.7 Novartis
    • 11.3.8 Sanofi
    • 11.3.9 Pfizer
    • 11.3.10 Teva Pharmaceutical

List of Figures

List of Figures

  • Figure 1: Global deaths associated with bacterial antimicrobial resistance by infectious syndrome, 2019
  • Figure 2: Global Cephalosporin Drug Market Size, By Value, 2019-2022 (USD Million)
  • Figure 3: Global Cephalosporin Drug Market Size, By Value, 2023-2029 (USD Million)
  • Figure 4: Global Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 5: Global Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 6: Global Cephalosporin Drug Market Absolute Opportunity, By First Generation, 2019H-2029F (USD Million)
  • Figure 7: Global Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 8: Global Cephalosporin Drug Market Absolute Opportunity, By Second Generation, 2019H-2029F (USD Million)
  • Figure 9: Global Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 10: Global Cephalosporin Drug Market Absolute Opportunity, By Third Generation, 2019H-2029F (USD Million)
  • Figure 11: Global Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 12: Global Cephalosporin Drug Market Absolute Opportunity, By Fourth Generation, 2019H-2029F (USD Million)
  • Figure 13: Global Cephalosporin Drug Market Size, By Fifth Generation , By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 14: Global Cephalosporin Drug Market Absolute Opportunity, By Fifth Generation, 2019H-2029F (USD Million)
  • Figure 15: Global Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 16: Global Cephalosporin Drug Market Absolute Opportunity, By Oral, 2019H-2029F (USD Million)
  • Figure 17: Global Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 18: Global Cephalosporin Drug Market Absolute Opportunity, By Parenteral, 2019H-2029F (USD Million)
  • Figure 19: Global Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 20: Global Cephalosporin Drug Market Absolute Opportunity, By Respiratory Tract Infection, 2019H-2029F (USD Million)
  • Figure 21: Global Cephalosporin Drug Market Size, By Skin Infection , By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 22: Global Cephalosporin Drug Market Absolute Opportunity, By Skin Infection , 2019H-2029F (USD Million)
  • Figure 23: Global Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 24: Global Cephalosporin Drug Market Absolute Opportunity, By Urinary Tract Infection, 2019H-2029F (USD Million)
  • Figure 25: Global Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 26: Global Cephalosporin Drug Market Absolute Opportunity, By Others, 2019H-2029F (USD Million)
  • Figure 27: Americas Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 28: Americas Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 29: Americas Cephalosporin Drug Market, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 30: Americas Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 31: Americas Cephalosporin Drug Market, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 32: Americas Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 33: Americas Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 34: Americas Cephalosporin Drug Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 35: Americas Cephalosporin Drug Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 36: Americas Cephalosporin Drug Market, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 37: Americas Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 38: Americas Cephalosporin Drug Market, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 39: Americas Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 40: United States Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 41: United States Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 42: United States Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 43: United States Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 44: United States Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 45: Canada Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 46: Canada Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 47: Canada Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 48: Canada Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 49: Canada Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 50: Rest of Americas Cephalosporin Drug Market , By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 51: Rest of Americas Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 52: Rest of Americas Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 53: Rest of Americas Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 54: Rest of Americas Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 55: Europe Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 56: Europe Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 57: Europe Cephalosporin Drug Market, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 58: Europe Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 59: Europe Cephalosporin Drug Market, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 60: Europe Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 61: Europe Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 62: Europe Cephalosporin Drug Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 63: Europe Cephalosporin Drug Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 64: Europe Cephalosporin Drug Market, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 65: Europe Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 66: Europe Cephalosporin Drug Market, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 67: Europe Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 68: United Kingdom Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 69: United Kingdom Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 70: United Kingdom Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 71: United Kingdom Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 72: United Kingdom Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 73: Germany Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 74: Germany Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 75: Germany Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 76: Germany Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 77: Germany Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 78: France Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 79: France Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 80: France Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 81: France Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 82: France Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 83: Italy Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 84: Italy Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 85: Italy Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 86: Italy Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 87: Italy Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 88: Rest of Europe Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 89: Rest of Europe Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 90: Rest of Europe Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 91: Rest of Europe Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 92: Rest of Europe Cephalosporin Drug MarketShare, By Application, By Value, 2022 (%)
  • Figure 93: Asia-Pacific Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 94: Asia-Pacific Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 95: Asia-Pacific Cephalosporin Drug Market, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 96: Asia-Pacific Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 97: Asia-Pacific Cephalosporin Drug Market, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 98: Asia-Pacific Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 99: Asia-Pacific Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 100: Asia-Pacific Cephalosporin Drug Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 101: Asia-Pacific Cephalosporin Drug Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 102: Asia-Pacific Cephalosporin Drug Market, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 103: Asia-Pacific Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 104: Asia-Pacific Cephalosporin Drug Market, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 105: Asia-Pacific Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 106: China Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 107: China Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 108: China Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 109: China Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 110: China Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 111: Japan Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 112: Japan Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 113: Japan Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 114: Japan Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 115: Japan Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 116: South Korea Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 117: South Korea Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 118: South Korea Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 119: South Korea Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 120: South Korea Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 121: India Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 122: India Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 123: India Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 124: India Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 125: India Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 126: Rest of Asia-Pacific Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 127: Rest of Asia-Pacific Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 128: Rest of Asia-Pacific Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 129: Rest of Asia-Pacific Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 130: Rest of Asia-Pacific Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 131: Middle East and Africa Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 132: Middle East and Africa Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 133: Middle East and Africa Cephalosporin Drug Market , By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 134: Middle East and Africa Cephalosporin Drug Market , By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 135: Middle East and Africa Cephalosporin Drug Market , By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 136: Middle East and Africa Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 137: Middle East and Africa Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 138: Middle East and Africa Cephalosporin Drug Market , By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 139: Middle East and Africa Cephalosporin Drug Market , By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 140: Middle East and Africa Cephalosporin Drug Market , By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 141: Middle East and Africa Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 142: Middle East and Africa Cephalosporin Drug Market , By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 143: Middle East and Africa Cephalosporin Drug Market , By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 144: Global Impact of Drivers and Restraints
  • Figure 145: Market Share of Prominent Companies of Cephalosporin Drug, 2022 (%)
  • Figure 146: Lupin Revenues, 2020-2022 (USD Million)
  • Figure 147: Lupin Revenues, By Geographic Segments, 2022 (%)
  • Figure 148: Lupin Revenue , By Business Segments, 2022 (%)
  • Figure 149: Baxter International Revenues, 2020-2022 (USD Million)
  • Figure 150: Baxter International Revenues, By Geographic Segments, 2022 (%)
  • Figure 151: Baxter International Revenue , By Business Segments, 2022 (%)
  • Figure 152: Roche Revenues, 2020-2022 (USD Million)
  • Figure 153: Roche Revenue , By Business Segment, 2022 (%)
  • Figure 154: Eli Lilly and Company Revenues, 2020-2022 (USD Million)
  • Figure 155: Eli Lilly and Company Revenues, By Geographic Segments, 2022 (%)
  • Figure 156: Eli Lilly and Company Revenue , By Therapeutic Area, 2022 (%)
  • Figure 157: Abbott Laboratories Revenues, 2020-2022 (USD Million)
  • Figure 158: Abbott Laboratories Revenues, By Geographic Segments, 2022 (%)
  • Figure 159: Abbott Laboratories Revenue , By Business Segments, 2022 (%)
  • Figure 160: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
  • Figure 161: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
  • Figure 162: Merck & Co., Inc. Revenue , By Business Segments, 2022 (%)
  • Figure 163: Novartis Revenues, 2020-2022 (USD Million)
  • Figure 164: Novartis Revenue , By Business Segments, 2022 (%)
  • Figure 165: Novartis Revenue , By Geographical Segments, 2022 (%)
  • Figure 166: Sanofi Revenues, 2020-2022 (USD Million)
  • Figure 167: Sanofi Revenues, By Geographic Segments, 2022 (%)
  • Figure 168: Sanofi Revenue , By Business Segments, 2022 (%)
  • Figure 169: Pfizer Revenues, 2020-2022 (USD Million)
  • Figure 170: Pfizer Revenues, By Business Segments, 2022 (%)
  • Figure 171: Pfizer Inc. Revenue , By Geographical Segments, 2022 (%)
  • Figure 172: Teva Pharmaceuticals Revenues, 2020-2022 (USD Million)
  • Figure 173: Teva Pharmaceuticals Revenue , By Geographical Segments, 2022 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Cephalosporin Drug in Pipeline

Table A3: United States Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A4: United States Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A5: United States Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A6: United States Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A7: United States Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A8: United States Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A9: Canada Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A10: Canada Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A11: Canada Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A12: Canada Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A13: Canada Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A14: Canada Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A15: Rest of Americas Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A16: Rest of Americas Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A17: Rest of Americas Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A18: Rest of Americas Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A19: Rest of Americas Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A20: Rest of Americas Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A21: United Kingdom Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A22: United Kingdom Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A23: United Kingdom Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A24: United Kingdom Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A25: United Kingdom Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A26: United Kingdom Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A27: Germany Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A28: Germany Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A29: Germany Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A30: Germany Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A31: Germany Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A32: Germany Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A33: France Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A34: France Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A35: France Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A36: France Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A37: France Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A38: France Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A39: Italy Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A40: Italy Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A41: Italy Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A42: Italy Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A43: Italy Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A44: Italy Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A45: Rest of Europe Cephalosporin Drug Market , By Generation, By Value, 2019-2022 (USD Million)

Table A46: Rest of Europe Cephalosporin Drug Market , By Generation, By Value, 2023-2029 (USD Million)

Table A47: Rest of Europe Cephalosporin Drug Market , By Route of Administration, By Value, 2019-2022 (USD Million)

Table A48: Rest of Europe Cephalosporin Drug Market , By Route of Administration, By Value, 2023-2029 (USD Million)

Table A49: Rest of Europe Cephalosporin Drug Market , By Application, By Value, 2019-2022 (USD Million)

Table A50: Rest of Europe Cephalosporin Drug Market , By Application, By Value, 2023-2029 (USD Million)

Table A51: China Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A52: China Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A53: China Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A54: China Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A55: China Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A56: China Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A57: Japan Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A58: Japan Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A59: Japan Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A60: Japan Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A61: Japan Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A62: Japan Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A63: South Korea Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A64: South Korea Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A65: South Korea Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A66: South Korea Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A67: South Korea Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A68: South Korea Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A69: India Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A70: India Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A71: India Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A72: India Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A73: India Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A74: India Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A75: Rest of Asia-Pacific Cephalosporin Drug Market, By Generation Industry, By Value, 2019-2022 (USD Million)

Table A76: Rest of Asia-Pacific Cephalosporin Drug Market, By Generation Industry, By Value, 2023-2029 (USD Million)

Table A77: Rest of Asia-Pacific Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A78: Rest of Asia-Pacific Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A79: Rest of Asia-Pacific Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A80: Rest of Asia-Pacific Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A81: Lupin Key Financials, 2020-2022

Table A82: Baxter International Key Financials, 2020-2022

Table A83: Roche Key Financials, 2020-2022

Table A84: Eli Lilly and Company Key Financials, 2020-2022

Table A85: Abbott Laboratories Key Financials, 2020-2022

Table A86: Merck & Co., Inc. Key Financials, 2020-2022

Table A87: Novartis Key Company Financials, 2020-2022

Table A88: Sanofi Key Financials, 2020-2022

Table A89: Pfizer Key Financials, 2020-2022

Table A90: Teva Pharmaceuticals Key Company Financials, 2020-2022